Despite the wildtype p53 status of these tumors, the DNA damage-induced checkpoint response has been reported to be impaired in neuroblastomas through cytoplasmic sequestration of p53 [26, 27], although this remains controversial [31]. The gene discussed is TP53; the disease is neuroblastoma.